Product Details

Survanta Intratracheal

Beractant
25 mg/mL
Suspension

ROA

Intratracheal

Applicant Name

Phillips Pharmaceuticals (Nigeria) Limited

NRN

B4-9922

Status

Active


Composition

 

ATC Code

R07AA02  

Product Category

Drugs

Marketing Category

Prescription-only Medicine (POM)  

Packsize

 

Product Description

Intratracheal suspension in single-use glass vial. Each mL contains 25 mg of phospholipids suspended in 0.9% sodium chloride solution

Manufacturer Name

AbbVie Inc.

Manufacturer Country

INDIA  

Approval Date

2019-07-30  

Expiry Date

2024-07-29